Amanote Research

Amanote Research

    RegisterSign In

Home Monitoring Improves Endpoint Efficiency in Idiopathic Pulmonary Fibrosis

European Respiratory Journal - United Kingdom
doi 10.1183/13993003.02406-2016
Full Text
Open PDF
Abstract

Available in full text

Categories
MedicinePulmonaryRespiratory Medicine
Date

July 1, 2017

Authors
Kerri A. JohannsonEric VittinghoffJulie MorissetJoyce S. LeeJohn R. BalmesHarold R. Collard
Publisher

European Respiratory Society (ERS)


Related search

Idiopathic Pulmonary Fibrosis

Pulmonologiya
PulmonaryRespiratory Medicine
2015English

Idiopathic Pulmonary Fibrosis

2020English

Managing Comorbidities in Idiopathic Pulmonary Fibrosis

International Journal of General Medicine
Medicine
2015English

Cell Therapy in Idiopathic Pulmonary Fibrosis†

Medical Sciences
2018English

Serum Biomarkers in Idiopathic Pulmonary Fibrosis

Pulmonary Pharmacology and Therapeutics
BiochemistryMedicinePulmonaryRespiratory MedicinePharmacology
2010English

Cardiovascular Risk in Idiopathic Pulmonary Fibrosis

International Journal of Pulmonary & Respiratory Sciences
2018English

Idiopathic Pulmonary Fibrosis in Monozygotic Twins

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
1980English

Epigenomics of Idiopathic Pulmonary Fibrosis

American Journal of Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2012English

Idiopathic Pulmonary Fibrosis and Pirfenidone

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy